產(chǎn)品名稱 NKL 22 (MDK-4154) from BIOVISION, INC.
    產(chǎn)品貨號(hào) B1133-50
    產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
    產(chǎn)品規(guī)格 50 mg
    產(chǎn)品品牌 BIOVISION, INC.
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameNKL 22 (MDK-4154)
    DescriptionNKL 22 (also known as MDK-4154) is a cell-permeable compound that acts as a FXN- (frataxin gene) specific HDAC (histone deacetylase) inhibitor. It reverses the silencing of FXN transcription in FRDA (Friedreich's ataxia) cells due to hypoacetylation of histones H3 and H4 by increasing acetylation at H3K14, H4K12, and H4K5 without much acetylation on H3K9, H4K8 and H4K16. MW: 325.4. Purity ≥98% by HPLC
    Size50 mg
    Concentrationn/a
    Applicationsn/a
    Other NamesN1-(2-aminophenyl)-N7-phenylheptanediamide
    Gene, Accession, CAS #CAS: 537034-15-4
    Catalog #B1133-50
    Price
    Order / More InfoNKL 22 (MDK-4154) from BIOVISION, INC.
    Product Specific Referencesn/a
    產(chǎn)品資料 
    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>

    3. 

    <th id="itm00"></th>